Validation of a brief screening instrument for substance abuse and mental illness in HIV-positive patients.

PubWeight™: 1.09‹?› | Rank: Top 10%

🔗 View Article (PMID 16280698)

Published in J Acquir Immune Defic Syndr on December 01, 2005

Authors

Brian Wells Pence1, Bradley N Gaynes, Kathryn Whetten, Joseph J Eron, Robert W Ryder, William C Miller

Author Affiliations

1: Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7160, USA.

Articles citing this

The impact of mental health and traumatic life experiences on antiretroviral treatment outcomes for people living with HIV/AIDS. J Antimicrob Chemother (2009) 1.38

Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient population. Psychosom Med (2008) 1.19

"Please Don't Make Me Ask for Help": Implicit Social Support and Mental Health in Chinese Individuals Living with HIV. AIDS Behav (2015) 0.91

The role of adverse physical health events on the utilization of mental health services. Health Serv Res (2012) 0.90

Delivery of an HIV prevention counseling program in an infectious diseases clinic: implementation process and lessons learned. AIDS Patient Care STDS (2009) 0.86

Structural Ecosystems Therapy for HIV+ African-American women and drug abuse relapse. Fam Process (2010) 0.84

Validation of a New Three-Item Self-Report Measure for Medication Adherence. AIDS Behav (2016) 0.80

Prevalence estimation and validation of new instruments in psychiatric research: an application of latent class analysis and sensitivity analysis. Psychol Assess (2009) 0.79

Prefrontal cortical thinning in HIV infection is associated with impaired striatal functioning. J Neural Transm (Vienna) (2016) 0.78

Predictors of poor adherence among people on antiretroviral treatment in Cape Town, South Africa: a case-control study. AIDS Care (2015) 0.78

Three types of self-efficacy associated with medication adherence in patients with co-occurring HIV and substance use disorders, but only when mood disorders are present. J Multidiscip Healthc (2013) 0.77

Implementation of PHQ-9 depression screening for HIV-infected patients in a real-world setting. J Assoc Nurses AIDS Care (2013) 0.75

Anxiety symptoms and disorders among adults living with HIV and AIDS: A critical review and integrative synthesis of the empirical literature. Clin Psychol Rev (2016) 0.75

Poor CD4 count is a predictor of untreated depression in human immunodeficiency virus-positive African-Americans. World J Psychiatry (2016) 0.75

Exploring the HIV continuum of care among young black MSM. PLoS One (2017) 0.75

Spiritual care may impact mental health and medication adherence in HIV+ populations. HIV AIDS (Auckl) (2017) 0.75

Articles by these authors

Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med (2009) 19.90

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA (2008) 11.72

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61

Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA (2012) 8.94

Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol (2005) 8.67

Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis (2004) 8.30

Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2002) 7.78

Detection of acute infections during HIV testing in North Carolina. N Engl J Med (2005) 7.60

The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet (2011) 5.87

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America. N Engl J Med (2003) 5.79

The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy. AIDS (2009) 5.72

Untreated gonococcal and chlamydial infection in a probability sample of adults. JAMA (2002) 5.07

Sexual and drug behavior patterns and HIV and STD racial disparities: the need for new directions. Am J Public Health (2006) 4.73

The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry (2005) 4.45

Screening for depression in adult patients in primary care settings: a systematic evidence review. Ann Intern Med (2009) 4.17

Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis (2010) 3.72

Young age at first sexual intercourse and sexually transmitted infections in adolescents and young adults. Am J Epidemiol (2005) 3.69

High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men. PLoS Pathog (2010) 3.68

Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study. Lancet (2005) 3.48

Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Int J Epidemiol (2007) 3.46

Novel therapies based on mechanisms of HIV-1 cell entry. N Engl J Med (2003) 3.32

The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial. PLoS Med (2010) 3.24

Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis (2006) 3.17

Detection of acute HIV infection: a field evaluation of the determine® HIV-1/2 Ag/Ab combo test. J Infect Dis (2011) 3.16

HIV incidence and factors associated with HIV acquisition among injection drug users in St Petersburg, Russia. AIDS (2006) 3.05

Spectrum bias or spectrum effect? Subgroup variation in diagnostic test evaluation. Ann Intern Med (2002) 2.99

Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial. JAMA (2002) 2.96

Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population. JAMA (2002) 2.94

Assessment by meta-analysis of PCR for diagnosis of smear-negative pulmonary tuberculosis. J Clin Microbiol (2003) 2.93

Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1. J Virol (2004) 2.91

The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults. AIDS Res Hum Retroviruses (2002) 2.89

Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells. AIDS (2008) 2.87

Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women. Clin Infect Dis (2007) 2.85

Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study. J Acquir Immune Defic Syndr (2013) 2.78

Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians. Ann Intern Med (2008) 2.65

HIV partner notification is effective and feasible in sub-Saharan Africa: opportunities for HIV treatment and prevention. J Acquir Immune Defic Syndr (2011) 2.49

HIV Infection and AIDS in the Deep South. Am J Public Health (2006) 2.46

Rapid, real-time detection of acute HIV infection in patients in Africa. J Infect Dis (2006) 2.44

Frequent detection of acute primary HIV infection in men in Malawi. AIDS (2004) 2.43

Screening for and treatment of suicide risk relevant to primary care: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med (2013) 2.36

Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Ann Intern Med (2011) 2.31

Acute HIV revisited: new opportunities for treatment and prevention. J Clin Invest (2004) 2.30

Barriers to antiretroviral adherence: the importance of depression, abuse, and other traumatic events. AIDS Patient Care STDS (2006) 2.30

Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection. Proc Natl Acad Sci U S A (2012) 2.27

Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modification. AIDS (2008) 2.25

Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease. Mov Disord (2007) 2.24

Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262). AIDS (2011) 2.22

Deployment and the use of mental health services among U.S. Army wives. N Engl J Med (2010) 2.21

Late entry to HIV care among Latinos compared with non-Latinos in a southeastern US cohort. Clin Infect Dis (2011) 2.20

Prevalence of HIV infection among young adults in the United States: results from the Add Health study. Am J Public Health (2006) 2.17

Moving forward in HIV-associated cancer. J Clin Oncol (2014) 2.14

Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials. Clin Infect Dis (2010) 2.14

Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection. PLoS Med (2009) 2.11

Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clin Infect Dis (2009) 2.05

Barriers to asymptomatic screening and other STD services for adolescents and young adults: focus group discussions. BMC Public Health (2004) 2.03

Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2007) 2.02

Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States. J Acquir Immune Defic Syndr (2006) 2.01

A tale of two countries: rethinking sexual risk for HIV among young people in South Africa and the United States. J Adolesc Health (2011) 2.00

A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy. AIDS (2003) 1.99

Evaluation of risk score algorithms for detection of chlamydial and gonococcal infections in an emergency department setting. Acad Emerg Med (2008) 1.98

How trauma, recent stressful events, and PTSD affect functional health status and health utilization in HIV-infected patients in the south. Psychosom Med (2005) 1.98

Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era. J Natl Cancer Inst (2013) 1.96

Infrequent diagnosis of primary human immunodeficiency virus infection: missed opportunities in acute care settings. Arch Intern Med (2003) 1.96

Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy. Clin Infect Dis (2011) 1.91

Improved detection of acute HIV-1 infection in sub-Saharan Africa: development of a risk score algorithm. AIDS (2007) 1.89

Effects of HIV-1 serostatus, HIV-1 RNA concentration, and CD4 cell count on the incidence of malaria infection in a cohort of adults in rural Malawi. J Infect Dis (2005) 1.88

Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trials. J Acquir Immune Defic Syndr (2005) 1.87

Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder. Ann Intern Med (2005) 1.83

Incarceration and risky sexual partnerships in a southern US city. J Urban Health (2007) 1.83

Older adults, chronic disease and leisure-time physical activity. Gerontology (2008) 1.83

HIV prevalence, sociodemographic, and behavioral correlates and recruitment methods among injection drug users in St. Petersburg, Russia. J Acquir Immune Defic Syndr (2006) 1.77

Factors associated with fewer visits for HIV primary care at a tertiary care center in the Southeastern U.S. AIDS Care (2006) 1.76

HIV treatment as prevention: debate and commentary--will early infection compromise treatment-as-prevention strategies? PLoS Med (2012) 1.76

Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data. Ann Intern Med (2014) 1.75

Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients: 4 year follow-up study. AIDS (2004) 1.74

The influence of psychosocial characteristics and race/ethnicity on the use, duration, and success of antiretroviral therapy. J Acquir Immune Defic Syndr (2008) 1.72

Does group A beta-hemolytic streptococcal infection increase risk for behavioral and neuropsychiatric symptoms in children? Arch Pediatr Adolesc Med (2004) 1.71

Splines for trend analysis and continuous confounder control. Epidemiology (2011) 1.69

Pre-exposure prophylaxis and antiretroviral resistance: HIV prevention at a cost? Clin Infect Dis (2011) 1.68

Relation of lifetime trauma and depressive symptoms to mortality in HIV. Am J Psychiatry (2007) 1.68

Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report. Am J Psychiatry (2007) 1.67

A self-administered Graded Repetitive Arm Supplementary Program (GRASP) improves arm function during inpatient stroke rehabilitation: a multi-site randomized controlled trial. Stroke (2009) 1.67

Deployment and mental health diagnoses among children of US Army personnel. Arch Pediatr Adolesc Med (2011) 1.66

Interventions to prevent post-traumatic stress disorder: a systematic review. Am J Prev Med (2013) 1.64

HIV testing and counseling leads to immediate consistent condom use among South African stable HIV-discordant couples. J Acquir Immune Defic Syndr (2013) 1.64

Copy-years viremia as a measure of cumulative human immunodeficiency virus viral burden. Am J Epidemiol (2009) 1.63

Increase in work productivity of depressed individuals with improvement in depressive symptom severity. Am J Psychiatry (2013) 1.61

Timing and duration of incarceration and high-risk sexual partnerships among African Americans in North Carolina. Ann Epidemiol (2008) 1.60

Gender difference in HIV RNA levels: a meta-analysis of published studies. J Acquir Immune Defic Syndr (2002) 1.59

Development and validation of a PCR-based enzyme-linked immunosorbent assay with urine for use in clinical research settings to detect Trichomonas vaginalis in women. J Clin Microbiol (2002) 1.58

Enrollment, retention, and visit attendance in the University of North Carolina Center for AIDS Research HIV clinical cohort, 2001-2007. AIDS Res Hum Retroviruses (2010) 1.58

Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections. PLoS Pathog (2011) 1.57